Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
IDEAYA Biosciences ( (IDYA) ) has shared an announcement.
On February 10, 2025, IDEAYA Biosciences, a company in the biotechnology sector, announced the appointment of Joshua Bleharski, Ph.D. as its new Chief Financial Officer, effective early May 2025. Dr. Bleharski brings extensive experience from J.P. Morgan, where he served as Managing Director and Global Co-Head of Biopharma, advising on capital markets and corporate strategies. This appointment is expected to strengthen IDEAYA’s leadership team, potentially enhancing its market strategies and investor relations in the biopharma industry.
More about IDEAYA Biosciences
YTD Price Performance: -8.59%
Average Trading Volume: 923,084
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.99B
For an in-depth examination of IDYA stock, go to TipRanks’ Stock Analysis page.